2002•The Practical Journal of CancerRequires access

Clinical Significance of Serum TSGF in Nasopharyngeal Carcinoma

Tao Liu

Open publisher page 0 citations

Abstract

Objective To determine the correlation between the level of serum tumor supplies group of factors (TSGF)and clinicopathologic features in patient with nasopharynegal carcinoma(NPC).Methods TSGF was measured by spectrophotometry in 134 healthy controls and 322 patients with NPC(179 initiated tumors,59 recurrent tumors and 84 after treatment).Results The TSGF level( ±s ) was(54.5±5.2) U/ml for healthy control,(65.2±12.1) U/ml for initiated tumor,and(72.9±12.4) U/ml for recurrent tumor,there were significant differences among these values( P 0.01),Profoundly differences were observed when patients were categorized with distant metastasis( P 0.01) and TNM stage( P 0.05).At the mean level of healthy subjects(55 U/ml),TSGF indicated a NPC with a specificity of 56.7%,a sensitivity of 81.0%,a positive predictive value of 71.4%,and a negative predictive value of 80.5%.At mean concentration of the distant metastasis free group(62 U/ml),determination of TSGF was able to exclude distant metastasis with a negative predictive value of 96.1%,a sensitivity of 93.9%,and a specificity of 48.4%.The patients who achived a partial or complete response to chemoradiotherapy had significantly less TSGF compared with the nonresponders( P 0.01).Conclusion A high level of TSGF is associated with tumor progression,poor treatment response,and especially distant metastasis in patients with NPC.

About this research paper

What this paper is about

Objective To determine the correlation between the level of serum tumor supplies group of factors (TSGF)and clinicopathologic features in patient with nasopharynegal carcinoma(NPC).Methods TSGF was measured by spectrophotometry in 134 healthy controls and 322 patients with NPC(179 initiated tumors,59 recurrent tumors and 84 after treatment).Results The TSGF level( ±s ) was(54.5±5.2) U/ml for healthy control,(65.2±12.1) U/ml for initiated tumor,and(72.9±12.4) U/ml for recurrent tumor,there were significant differences among these values( P 0.01),Profoundly differences were observed when patients were categorized with distant metastasis( P 0.01) and TNM stage( P 0.05).At the mean level of healthy subjects(55 U/ml),TSGF indicated a NPC with a specificity of 56.7%,a sensitivity of 81.0%,a positive predictive value of 71.4%,and a negative predictive value of 80.5%.At mean concentration of the distant metastasis free group(62 U/ml),determination of TSGF was able to exclude distant metastasis with a negative predictive value of 96.1%,a sensitivity of 93.9%,and a specificity of 48.4%.The patients who achived a partial or complete response to chemoradiotherapy had significantly less TSGF compared with the nonresponders( P 0.01).Conclusion A high level of TSGF is associated with tumor progression,poor treatment response,and especially distant metastasis in patients with NPC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To determine the correlation between the level of serum tumor supplies group of factors (TSGF)and clinicopathologic features in patient with nasopharynegal carcinoma(NPC).Methods TSGF was measured by spectrophotometry in 134 healthy controls and 322 patients with NPC(179 initiated tumors,59 recurrent tumors and 84 after treatment).Results The TSGF level( ±s ) was(54.5±5.2) U/ml for healthy control,(65.2±12.1) U/ml for initiated tumor,and(72.9±12.4) U/ml for recurrent tumor,there were significant differences among these values( P 0.01),Profoundly differences were observed when patients were categorized with distant metastasis( P 0.01) and TNM stage( P 0.05).At the mean level of healthy subjects(55 U/ml),TSGF indicated a NPC with a specificity of 56.7%,a sensitivity of 81.0%,a positive predictive value of 71.4%,and a negative predictive value of 80.5%.At mean concentration of the distant metastasis free group(62 U/ml),determination of TSGF was able to exclude distant metastasis with a negative predictive value of 96.1%,a sensitivity of 93.9%,and a specificity of 48.4%.The patients who achived a partial or complete response to chemoradiotherapy had significantly less TSGF compared with the nonresponders( P 0.01).Conclusion A high level of TSGF is associated with tumor progression,poor treatment response,and especially distant metastasis in patients with NPC.

Key concepts: Internal medicine, Distant metastasis, Medicine, Nasopharyngeal carcinoma, Gastroenterology, Stage (stratigraphy), Predictive value, Metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Significance of Serum TSGF in Nasopharyngeal Carcinoma — Research Paper | ScholarLens